S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

These Are the Five Best and Worst Performing Small-cap Stocks in Q2 2022

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

The small-cap Russell 2000 Index dropped over 23% in the first half of 2022, the worst first-half performance in its more than 40-year history. In the second quarter, the small-cap Russell 2000 Index dropped over 17%, slightly more than the large-cap Russell 1000 Index, which dropped over 16% in the same period. Let’s take a look at the five best and worst performing small-cap stocks in Q2 2022.

Five Best Performing Small-Cap Stocks In Q2 2022

We have used the quarterly return data of the small-cap stocks from finviz.com to come up with the five best and worst performing small-cap stocks in Q2 2022. First, let’s take a look at the five best performing small-cap stocks in Q2 2022.

Q2 2022 hedge fund letters, conferences and more

 

  1. Day One Biopharmaceuticals (82%)

Founded in 2018 and headquartered in South San Francisco, Calif., this company develops targeted therapies for patients with genetically defined cancers. Day One Biopharmaceuticals Inc NASDAQ: DAWN shares are up by over 7% year to date but are down by over 21% in the last year. As of writing, Day One Biopharmaceuticals shares were trading at over $18 (52-week range of $5.44 to $28.70), giving it a market capitalization of more than $1.20 billion.


  1. Altimmune (93%)

Founded in 1997 and headquartered in Gaithersburg, Md., it is a clinical-stage biopharmaceutical company that develops peptide-based therapeutics for obesity and liver diseases. Altimmune Inc NASDAQ: ALT shares are up by almost 43% year to date and up over 44% in the last year. As of this writing, Altimmune shares were trading at $13.49 (52-week range of $3.83 to $17.26), giving it a market capitalization of more than $560 million.

  1. Veru (128%)

Founded in 1996 and headquartered in Miami, it is a biopharmaceutical company that develops novel medicines for managing prostate cancer and breast cancer. Veru Inc NASDAQ: VERU shares are up by over 139% year to date and up over 103% in the last year. As of this writing, Veru shares were trading at $14.91 (52-week range of $4.34 to $18.40), giving it a market capitalization of more than $1.10 billion.

  1. Biomea Fusion (173%)

Founded in 2017 and headquartered in Redwood City, Calif., it is a biopharmaceutical company that develops irreversible small molecules to treat patients with genetically defined cancers. Biomea Fusion Inc NASDAQ: BMEA shares are up by almost 49% year to date but are down by over 12% in the last year. As of writing, Biomea Fusion shares were trading at $11.07 (52-week range of $2.84 to $14.95), giving it a market capitalization of more than $320 million.

  1. Redbox Entertainment (181%)

Founded in 2002 and headquartered in Oakbrook Terrace, Ill., this company produces, acquires, and distributes movies through its Redbox Entertainment label. Redbox Entertainment Inc NASDAQ: RDBX shares are down by almost 59% year to date and down over 69% in the last year. As of this writing, Redbox Entertainment shares were trading at $3.20 (52-week range of $1.6101 to $27.2200), giving it a market capitalization of more than $140 million.

Five Worst Performing Small-Cap Stocks In Q2 2022

  1. GreenLight Biosciences Holdings (-77%)

Founded in 2008 and headquartered in Medford, Mass., it is a biotechnology company that makes ribonucleic acid (RNA) products for human therapies and agriculture. Greenlight Biosciences Holdings PBC NASDAQ: GRNA shares are down by over 79% year to date and down over 78% in the last year. As of this writing, GreenLight Biosciences shares were trading at $2.19 (52-week range of $1.91 to $15.80), giving it a market capitalization of more than $250 million.

  1. Bed Bath & Beyond (-78%)

Founded in 1971 and headquartered in Union, N.J., this company retails domestic merchandise and home furnishings products. Bed Bath & Beyond Inc NASDAQ: BBBY shares are down by almost 65% year to date and down almost 83% in the last year. As of this writing, Bed Bath & Beyond shares were trading at $5.12 (52-week range of $4.38 to $30.14), giving it a market capitalization of more than $400 million.

  1. Riot Blockchain (-81%)

Founded in 2000 and headquartered in Castle Rock, Colo., it is a bitcoin mining company that offers special cryptocurrency mining computers. Riot Blockchain Inc NASDAQ: RIOT shares are down by over 68% year to date and down over 70% in the last year. As of this writing, Riot Blockchain shares were trading at $6.85 (52-week range of $4.02 to $46.28), giving it a market capitalization of more than $960 million.

  1. Marathon Digital Holdings (-82%)

Founded in 2010 and headquartered in Las Vegas, Nev., it is a digital asset technology company that mines cryptocurrencies. Marathon Digital Holdings Inc NASDAQ: MARA shares are down by over 62% year to date and down over 58% in the last year. As of this writing, Marathon Digital Holdings shares were trading at $11.70 (52-week range of $5.20 to $83.45), giving it a market capitalization of more than $1.30 billion.

  1. Core Scientific (-82%)

Founded in 2017 and headquartered in Austin, Texas, this company offers carbon neutral blockchain infrastructure, as well as software solutions. Core Scientific Inc NASDAQ: CORZ shares are down by over 83% year to date and down almost 82% in the last year. As of this writing, Core Scientific shares were trading at $1.78 (52-week range of $1.40 to $14.98), giving it a market capitalization of more than $590 million.

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Where should you invest $1,000 right now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Day One Biopharmaceuticals (DAWN)
2.0635 of 5 stars
$15.75+6.1%N/A-6.62Moderate Buy$40.60
Altimmune (ALT)
1.1526 of 5 stars
$6.89-2.1%N/A-4.18Moderate Buy$15.00
Veru (VERU)
1.2129 of 5 stars
$1.42+22.4%N/A-1.89Moderate Buy$3.33
Biomea Fusion (BMEA)
1.5281 of 5 stars
$11.16-3.0%N/A-3.23Moderate Buy$53.13
Redbox Entertainment (RDBX)
0 of 5 stars
$1.65flatN/AN/AN/A
GreenLight Biosciences (GRNA)
0 of 5 stars
$0.30flatN/A-0.26N/A
Bed Bath & Beyond (BBBY)
0.2436 of 5 stars
$0.08flat861.85%-0.01N/A
Riot Platforms (RIOT)
3.5892 of 5 stars
$8.29+4.0%N/A-30.70Buy$18.96
Marathon Digital (MARA)
2.7559 of 5 stars
$15.03+2.7%N/A17.89Hold$21.11
Core Scientific (CORZ)
1.7063 of 5 stars
$2.88+6.7%N/AN/ABuy$6.75
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

7 Must-Buy Stocks Under $20

7 Must-Buy Stocks Under $20

In this video, we highlight seven stocks under $20 that are worth a closer look.

Search Headlines: